Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study
Latest Information Update: 02 May 2018
At a glance
- Drugs Perflubutane (Primary)
- Indications Liver cancer
- Focus Diagnostic use
- Acronyms SCAN
- 15 May 2017 New trial record
- 18 Apr 2017 Trial design published in the BMC Cancer.